Literature DB >> 22100808

Influence of population selection on the 99th percentile reference value for cardiac troponin assays.

Paul O Collinson1, Yen Ming Heung, David Gaze, Frances Boa, Roxy Senior, Robert Christenson, Fred S Apple.   

Abstract

OBJECTIVE: We sought to determine the effect of patient selection on the 99th reference percentile of 2 sensitive and 1 high-sensitivity (hs) cardiac troponin assays in a well-defined reference population.
METHODS: Individuals>45 years old were randomly selected from 7 representative local community practices. Detailed information regarding the participants was collected via questionnaires. The healthy reference population was defined as individuals who had no history of vascular disease, hypertension, or heavy alcohol intake; were not receiving cardiac medication; and had blood pressure<140/90 mmHg, fasting blood glucose<110 mg/dL (approximately 6 mmol/L), estimated creatinine clearance>60 mL·min(-1)·(1.73 m2)(-1), and normal cardiac function according to results of echocardiography. Samples were stored at -70 °C until analysis for cardiac troponin I (cTnI) and cardiac troponin T (cTnT) and N-terminal pro-B-type natriuretic peptide.
RESULTS: Application of progressively more stringent population selection strategies to the initial baseline population of 545 participants until the only individuals who remained were completely healthy according to the study criteria reduced the number of outliers seen and led to a progressive decrease in the 99th-percentile value obtained for the Roche hs-cTnT assay and the sensitive Beckman cTnI assay but not for the sensitive Siemens Ultra cTnI assay. Furthermore, a sex difference found in the baseline population for the hs-cTnT (P=0.0018) and Beckman cTnI assays (P<0.0001) progressively decreased with more stringent population selection criteria.
CONCLUSIONS: The reference population selection strategy significantly influenced the 99th percentile reference values determined for troponin assays and the observed sex differences in troponin concentrations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100808     DOI: 10.1373/clinchem.2011.171082

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  43 in total

Review 1.  High-sensitivity assays for troponin in patients with cardiac disease.

Authors:  Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg
Journal:  Nat Rev Cardiol       Date:  2017-04-06       Impact factor: 32.419

Review 2.  Making sense of high sensitivity troponin assays and their role in clinical care.

Authors:  Lori B Daniels
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

3.  High-sensitivity cardiac troponin testing for primary care: analytical assay considerations required before widespread implementation.

Authors:  Alan H B Wu
Journal:  Ann Transl Med       Date:  2016-07

Review 4.  High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.

Authors:  Vlad C Vasile; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

Review 5.  Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice.

Authors:  Nick S R Lan; Damon A Bell
Journal:  Clin Biochem Rev       Date:  2019-11

6.  High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore.

Authors:  Ziwei Lin; Swee Han Lim; Siang Jin Terrance Chua; E Shyong Tai; Yiong Huak Chan; Arthur Mark Richards
Journal:  Singapore Med J       Date:  2019-02-18       Impact factor: 1.858

7.  Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department.

Authors:  Peter A Kavsak; Johannes T Neumann; Louise Cullen; Martin Than; Colleen Shortt; Jaimi H Greenslade; John W Pickering; Francisco Ojeda; Jinhui Ma; Natasha Clayton; Jonathan Sherbino; Stephen A Hill; Matthew McQueen; Dirk Westermann; Nils A Sörensen; William A Parsonage; Lauren Griffith; Shamir R Mehta; P J Devereaux; Mark Richards; Richard Troughton; Chris Pemberton; Sally Aldous; Stefan Blankenberg; Andrew Worster
Journal:  CMAJ       Date:  2018-08-20       Impact factor: 8.262

8.  Obstructive sleep apnea: no independent association to troponins.

Authors:  Trygve Sørdahl Hall; Tobias Herrscher; Petr Jarolim; Morten W Fagerland; Torstein Jensen; Jonas Hallén; Stefan Agewall; Dan Atar
Journal:  Sleep Breath       Date:  2013-09-17       Impact factor: 2.816

9.  High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.

Authors:  Alexis L Beatty; Ivy A Ku; Robert H Christenson; Christopher R DeFilippi; Nelson B Schiller; Mary A Whooley
Journal:  JAMA Intern Med       Date:  2013-05-13       Impact factor: 21.873

10.  Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay.

Authors:  M Odette Gore; Stephen L Seliger; Christopher R Defilippi; Vijay Nambi; Robert H Christenson; Ibrahim A Hashim; Ron C Hoogeveen; Colby R Ayers; Wensheng Sun; Darren K McGuire; Christie M Ballantyne; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.